Tolremo
Swiss biotech company
Tolremo has raised €8.0M across 1 funding round from 2 investors, most recently a Series A round in Sep 2018. Based in Zurich, Switzerland; founded 2017; active in Healthtech. Data as of 31 Oct 2026.
Total raised
€8.0M
€8,015,675
Funding rounds
1
Investors
2
distinct backers
Active since
2018-09
latest 2018-09
Funding by year
EUR raised per yearTolremo — funding by year — interactive chart.
Data table
| Tolremo — funding by year | |
|---|---|
| 2018 | €8.0M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round- 2018-09-24Series A€8.0Mas well as existing shareholders Zürcher Kantonalbank,BioMedPartners with participation from Redalpine and Altos Venture
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-09-24 | Series A | €8.0M | as well as existing shareholders Zürcher Kantonalbank,BioMedPartners with participation from Redalpine and Altos Venture | View deal → |
Investors
2as well as existing shareholders Zürcher KantonalbankBioMedPartners with participation from Redalpine and Altos Venture
Related news
Similar companies
same sector, similar size- genomsys€8.5MSwitzerland · Healthtech
- Alentis Therapeutics€11MSwitzerland · Healthtech
- Resistell Ag€6.5MSwitzerland · Healthtech
- Luciole Medical€4.7MSwitzerland · Healthtech
- Strekin€12MSwitzerland · Healthtech
- RocketVax€6.7MSwitzerland · Healthtech
Global coverage: FundingData